Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-09-26FDA Approved: OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved the original application for a generic combination product, olmesartan medoxomil-hydrochlorothiazide, manufactured by Novad…
-
EMA approval · 2025-09-25EMA Authorised: Karvezide (irbesartan;hydrochlorothiazide) — Sanofi Winthrop Industrie
The EMA authorised Karvezide, a fixed-dose combination of irbesartan and hydrochlorothiazide, for the treatment of hypertension.
-
EMA approval · 2025-09-25EMA Authorised: CoAprovel (irbesartan;hydrochlorothiazide) — Sanofi Winthrop Industrie
The EMA authorised CoAprovel, a fixed-dose combination of irbesartan and hydrochlorothiazide, for hypertension.
-
FDA approval · 2025-09-23FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for labetalol hydrochloride by Macleods Pharmaceuticals Limited. Labetalol hydrochloride is a beta-blo…
-
FDA approval · 2025-09-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for verapamil hydrochloride from Amneal Pharmaceuticals LLC under ANDA210994. This approval authoriz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-09-17EMA Authorised: Revatio (sildenafil) — Upjohn EESV
EMA authorised Revatio (sildenafil) for use in hypertension and pulmonary arterial hypertension, with Upjohn EESV as the marketing authoriza…
-
FDA approval · 2025-09-16FDA Approved: IRBESARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for IRBESARTAN from Unichem Pharmaceuticals (USA), Inc., updating the regulatory status of this gene…
-
FDA approval · 2025-09-11FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride from Actavis Pharma, Inc., confirming/expanding the product's regulatory…
-
FDA approval · 2025-09-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium submitted by Aurobindo Pharma Limited.
-
FDA approval · 2025-09-08FDA Approved: FUROSEMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for furosemide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., updating/expandin…
-
FDA approval · 2025-08-28FDA Approved: LOPRESSOR — Original Application (VALIDUS PHARMACEUTICALS LLC)
FDA approved Lopressor (metoprolol tartrate) via the original application for METOPROLOL TARTRATE by Validus Pharmaceuticals LLC under NDA 2…
-
FDA approval · 2025-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride by Alembic Pharmaceuticals Inc. The action represents a supplemental reg…
-
FDA approval · 2025-08-06FDA Approved: FUROSEMIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic diuretic furosemide from Meitheal Pharmaceuticals Inc. under ANDA 212803.
-
FDA approval · 2025-08-06FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for a generic Losartan potassium and hydrochlorothiazide combination from Unichem Pharmaceuticals (U…
-
FDA approval · 2025-08-01FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2025-08-01FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for AVALIDE (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2025-08-01FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic fixed-dose combination tablet of olmesartan medoxomil and h…
-
FDA approval · 2025-07-30FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Atenolol submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2025-07-25FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic olmesartan medoxomil and hydrochlorothiazide tablet under an original ANDA.
-
FDA approval · 2025-07-25FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).
-
EMA approval · 2025-07-24EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited
The European Medicines Agency has authorized a fixed-dose combination of amlodipine besilate and valsartan (Amlodipine / Valsartan Mylan) fo…
-
FDA approval · 2025-07-24FDA Approved: SDAMLO — Original Application (Pangea Pharmaceuticals, LLC)
The FDA approved SDAMLO (amlodipine) under an Original Application (NDA 219531) by Pangea Pharmaceuticals, LLC.
-
FDA approval · 2025-07-23FDA Approved: VOSTALLY — Original Application (Rosemont Pharmaceuticals LLC)
The FDA approved VOSTALLY (ramipril) from Rosemont Pharmaceuticals LLC through an original application, introducing a branded ramipril produ…
-
FDA approval · 2025-07-18FDA Approved: OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the generic fixed-dose combination of olmesartan medoxomil, amlodipine, and hydrochlorothiazide for hypertension.
-
EMA approval · 2025-07-18EMA Authorised: Tolura (telmisartan) — Krka, d.d., Novo mesto
Tolura, a generic telmisartan product from Krka, has been authorised in the EU for hypertension.